Leveraging cutting-edge quantum detectors, we design light, portable, and performing MRI machines working at ultra-low magnetic fields for a tenth of current prices.
Astrape powers the future of datacenters: more bandwidth, less power.
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for chipmakers focused on next-generation digital communications systems, particularly 5G networks. Established in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the necessity for DSP co-processors, thereby enhancing design flexibility. VSORA's innovative DSP development flow enables collaboration between signal processing engineers and software engineers, allowing them to work within the same environment and share source code, which significantly accelerates the time-to-market for new products. The company's mission is to address technical challenges by optimizing DSP computing power while minimizing power consumption and silicon footprint, thereby improving overall system performance.
AMT Medical B.V., founded in 2015 and based in Ede, the Netherlands, specializes in developing innovative devices for heart bypass surgery. The company has created the AMT Heart Bypass System, which utilizes the ELANA bypass technique, originally developed by neurosurgeon Prof. Dr. C.A.F. Tulleken and his team. This minimal invasive approach aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, ultimately improving patient outcomes and recovery times. The AMT Heart Bypass System has completed its development and production processes, as well as all pre-clinical trials. A clinical multi-center trial is set to begin in late 2019 or early 2020, marking a significant step in bringing this advanced technology to the medical community.
Sparrow Quantum Aps. is a Danish company specializing in quantum technology, particularly in the development of advanced light-matter interfaces. The firm focuses on creating deterministic single-photon sources, which are essential for various quantum technologies. Sparrow Quantum boasts the highest efficiency for on-chip single-photon sources globally, characterized by exceptional photon purity, indistinguishability, and outcoupling capabilities. This cutting-edge technology is rooted in over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which the company holds exclusive licenses for key patents. By leveraging self-assembled quantum dots paired with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interactions, providing critical advancements for its clients in the field of photonic quantum technology.
FaradaIC Sensors focuses on developing miniaturized gas sensors aimed at enhancing dioxygen detection capabilities for electronic devices. By employing standard microfabrication techniques, the company effectively reduces both the size and power consumption of its sensors, leading to lower production costs. This innovative approach allows for the commoditization of gas sensors, making them accessible and affordable for a variety of Internet of Things applications. FaradaIC Sensors is positioned to capitalize on the growing demand for flexible and cost-effective gas sensing solutions in the expanding IoT market.
BlueHeart Energy is a deep tech company focused on developing innovative green technologies to enhance heat pump performance. Utilizing thermoacoustics, the company generates sound waves within a closed circuit to produce heat and cold, marking a significant advancement as this technology is now being applied to residential heat pumps, previously limited to industrial applications. BlueHeart's products are designed to replace critical components in heat pumps, facilitating easy integration for original equipment manufacturers. The resulting heat pumps are versatile, silent, and cost-effective, suitable for both new and existing homes. Additionally, BlueHeart's technology is environmentally friendly, producing no CO2 emissions and eliminating the need for refrigerants, thus contributing to sustainable heating and cooling solutions.
Marvel Fusion is a developer of fusion energy technology focused on providing environmentally friendly and safe energy solutions. Founded in 2019 and based in Munich, Bayern, the company specializes in a laser-based nuclear fusion reactor that utilizes short pulse, high energy, and electrically efficient lasers. This technology aims to commercialize baseload fusion electrical power, enabling consumers to access clean, safe, and reliable energy sources.
Brevel has developed an innovative cultivation technology focused on the sustainable and cost-effective production of microalgae. Utilizing high-tech, fully automated indoor systems that feature internal illumination, Brevel's approach achieves significant cost reductions and substantially higher yields compared to traditional methods. This advanced technology positions the company to tap into various markets in need of microalgae-derived products, including sustainable food, materials, chemicals, pharmaceuticals, and energy. By unlocking the full potential of microalgae, Brevel aims to create an alternative protein source suitable for mass production, addressing the increasing demand for environmentally friendly solutions across multiple industries.
QuantWare is a leading provider of quantum hardware, specializing in scalable quantum processors designed to enhance computational capabilities. The company has developed the VIO QPU scaling technology, which serves as a platform for various qubit designs, facilitating the development of quantum computers with the potential to exceed one million qubits. QuantWare operates under the Quantum Open Architecture paradigm, supplying fully packaged quantum processing units (QPUs) and offering Foundry and Packaging Services to clients in 20 countries across four continents. Its innovative 3D-dimensional chip architecture enables customers to build connected and scalable quantum systems, aimed at addressing complex challenges in fields such as climate and life sciences.
Skyfora is a company focused on enhancing weather observation and forecasting through innovative technology. It addresses the limitations of traditional weather data by utilizing patented GNSS Meteorology solutions and AI-enhanced forecasting methods. By repurposing GNSS receivers from telecom base stations, Skyfora transforms them into advanced 4D weather scanners, significantly increasing the volume of weather observation data generated from existing infrastructure. This innovative approach not only improves the performance of AI-driven weather forecasts but also contributes to global sustainability and climate change resilience. In addition, Skyfora develops forecasting software that leverages computer vision and IoT technologies to analyze satellite images, enhancing the scientific understanding of hurricanes and aiding disaster management efforts. This combination of advanced technology and sustainable practices positions Skyfora as a leader in the field of weather forecasting and climate resilience.
Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.
Stablepharma Ltd specializes in developing innovative processes for vaccine stabilization, focusing on its technology platform, StablevaX™, which transforms existing approved vaccines, therapeutics, and diagnostics into thermostable products that do not require refrigeration. This advancement addresses the global challenges associated with cold chain logistics, allowing for efficient and waste-free vaccine delivery. The company has identified up to 60 vaccine candidates suitable for its technology and collaborates with global vaccine manufacturers, academic institutions, and non-governmental organizations to enhance its pipeline of thermostable products. Founded in 2012 and based in Bath, United Kingdom, Stablepharma aims to reduce costs and carbon emissions while expanding access to vaccines for both children and adults.
MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
Deeploy is a developer of a machine learning operations platform focused on enhancing the accountability and transparency of AI systems. The platform centralizes explainable AI (XAI) within machine learning operations (MLOps), empowering users to comprehend how models function and to rectify automated decisions when necessary. By organizing deployments, tracking model performance, generating trace logs, and facilitating the creation of custom models and explainers, Deeploy provides data scientists and users with the tools needed to understand the implications and applications of machine learning models. This approach ensures that AI systems are both trustworthy and accountable.
ATMOS Space Cargo specializes in the development and manufacturing of space capsules designed to facilitate the return of cargo from space. Their products include return capsules and atmospheric decelerators that provide microgravity environments on demand. By offering varied time options in orbit, ATMOS Space Cargo enables clients to conduct life sciences research and other experiments in microgravity, addressing specific challenges in these fields. The company aims to support commercial ventures and scientific inquiries by providing reliable solutions for transporting goods and experiments back to Earth from space.
QDI Systems B.V. is a startup based in Groningen, the Netherlands, specializing in the development of advanced imaging devices for medical applications using quantum dot technology. The company focuses on creating X-ray sensors that deliver high-contrast and high-resolution mammograms, allowing for improved diagnostic capabilities while minimizing radiation exposure for patients. QDI Systems emphasizes user-friendliness by providing accessible quantum dot materials along with comprehensive instructions for constructing high-performance imaging devices. This approach enables healthcare professionals to obtain precise medical images, enhancing the overall efficacy of diagnostic procedures.
AlzeCure Pharma AB is a Swedish pharmaceutical company dedicated to the research and development of innovative diagnostics and therapeutics for neurodegenerative disorders, particularly Alzheimer's disease. The company operates through three main research platforms: NeuroRestore, Alzstatin, and Painless. Its portfolio includes several drug candidates currently in various stages of clinical development, such as ACD440 for neuropathic pain, and ACD856, ACD857, ACD679, and ACD680, which target Alzheimer's disease. Additionally, AlzeCure is developing ACD137 for the treatment of severe pain associated with conditions like osteoarthritis. With a focus on advancing novel projects, AlzeCure brings together professionals with diverse expertise to enhance the understanding and treatment of these complex diseases.
QDI Systems B.V. is a startup based in Groningen, the Netherlands, specializing in the development of advanced imaging devices for medical applications using quantum dot technology. The company focuses on creating X-ray sensors that deliver high-contrast and high-resolution mammograms, allowing for improved diagnostic capabilities while minimizing radiation exposure for patients. QDI Systems emphasizes user-friendliness by providing accessible quantum dot materials along with comprehensive instructions for constructing high-performance imaging devices. This approach enables healthcare professionals to obtain precise medical images, enhancing the overall efficacy of diagnostic procedures.
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.
Aplagon is a biopharmaceutical company focused on developing innovative antithrombotic medications aimed at addressing complications associated with vascular interventions, particularly blood vessel occlusions. The company specializes in creating biological mimetics of heparin proteoglycan, which are intended for the clinical management of thrombotic occlusions and ischemic reperfusion injuries. Aplagon's mission is to provide patients with effective treatment options that offer significant safety advantages, thereby fulfilling unmet medical needs in the field of vascular health.
TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.
Alcyon Photonics specializes in the design and development of integrated photonic devices, focusing on photonic building blocks that facilitate the creation, manipulation, and detection of light. Their product offerings include photonic intellectual property (IP) building blocks and platforms for the management and commercialization of photonic integrated circuits (PICs). Utilizing subwavelength grating technology, Alcyon Photonics enables advanced light management through innovative designs that integrate smoothly with circuit layout tools and commercial process design kits (PDKs). This compatibility supports customers in enhancing their designs and constructing circuits tailored to various applications, including optical communications, biochemical sensing, and spectrometry, particularly through the use of microsatellites.
dotLumen is a research startup that uses AI, robotics, and neuroscience to empower the blind. dotLumen was founded in 2020 and is headquartered in Cluj, Romania.
Photon IP is a deeptech startup located in Eindhoven, the Netherlands, focused on developing advanced technologies for photonics applications. The company specializes in application-specific semiconductors that cater to various sectors, including wearable electronics and data centers. By providing innovative solutions, Photon IP supports clients in industries such as automotive and telecommunications, aiming to enhance the functionality and efficiency of their products.
AQLAS is shaping the quantum future and discovering Next-Gen Lasers redefining quantum computing. Our high-quality hardware is set apart by its economical, compact, and efficient nature, thus paving the way for the proliferation of quantum computers.
Patient-specific right heart pumps that free patients from heavy battery packages and increase patient's quality of life.
Hervolution Therapeutics focuses on developing first-in-class immunotherapies to combat tumors from within. The company leverages Human Endogenous Retroviral proteins (HERVs) to create rationally designed immune therapeutics targeting the dark genome. Hervolution Therapeutics aims to address hidden enemies within the human body by pioneering innovative biotechnology solutions.
ION-X is a technology developer focused on creating efficient propulsion systems for small spacecraft, particularly in the satellite sector. The company specializes in electric propulsion that utilizes the ejection of finely ionized particles, achieving high thrust and specific impulse (ISP). This innovative approach offers a long operational lifespan, high modularity, and cost-effective production capabilities, making it suitable for mass production. ION-X aims to support the expanding aerospace market by providing advanced thruster solutions that meet the increasing demand for efficient and reliable propulsion technologies.
GBM Works B.V., founded in 2016 and headquartered in The Hague, Netherlands, specializes in the installation of offshore wind turbine foundations. The company has developed an innovative method known as the GBM Vibro-drill, which aims to minimize ocean noise during the installation process. This technology not only enhances the efficiency of installing turbine foundations but also addresses environmental concerns by reducing disruption to marine ecosystems and nearby communities. Through its advancements, GBM Works contributes to the growth of the renewable energy sector, facilitating the expansion of offshore operations in a sustainable manner.
FibriTech develops a technology for the production of 3D fibre network materials. They offer services that include agritech, packaging, filters, insulators, ecomaterials, fibritech, hydroponics, fibres, and biocomposites.
Acorai is developing a non-invasive heart failure monitoring platform centered on direct intracardiac pressure monitoring (ICPM). The company utilizes a patented combination of sensor technologies and machine learning to provide accurate and cost-efficient heart failure care. This innovative approach allows for non-invasive monitoring of cardiac and pulmonary pressure, which is crucial for improving outcomes in heart failure patients. By analyzing pressure dynamics through acoustic, vibratory, and waveform data, the device enables healthcare professionals to proactively adjust medications, potentially reducing re-hospitalization and mortality rates associated with heart failure. Clinically validated and designated as an FDA Breakthrough Device, Acorai's product is expected to enter the market in 2025.
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.
AISPECO is a Lithuanian company that specializes in geospatial monitoring systems for various types of vehicles, including helicopters, planes, unmanned aerial vehicles (UAVs), and terrestrial vehicles. The company develops aerial inspection systems specifically designed for conducting powerline surveys using helicopters and drones. Its platform is capable of capturing multiple types of imagery, such as optical, infrared, corona, and hyperspectral, which enhances the efficiency and effectiveness of infrastructure inspections. By focusing on advanced imaging technology, AISPECO enables clients to perform inspections with greater endurance and scalability in their operations.
Quantune is a deep tech startup specializing in optics and photonics technology. The company develops a compact infrared spectrometer that miniaturizes traditional laboratory equipment for molecular analysis, making it accessible for both biomedical consumer devices and industrial applications. This innovative spectrometer facilitates continuous and non-invasive health monitoring, allowing clients to achieve real-time monitoring and analysis of chemical compounds and emissions. By transforming large-scale laboratory processes into a portable module, Quantune enables novel applications in various fields, enhancing the capabilities of health and environmental monitoring.
Turing College is an online data science school that caters to individuals at various levels of expertise. The institution offers a pay-when-employed model, allowing students to learn at their own pace through a peer-driven remote learning platform. The curriculum is co-created with tech companies, ensuring that it is relevant to industry needs. This collaboration also enables companies to receive real-time updates on students' performance, facilitating quicker hiring decisions. By utilizing an income share agreement, Turing College allows students to pay for their education once they secure employment, making data science training more accessible.
Innoventric is a medical device company based in Ness-Ziona, Israel, focused on developing innovative percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company has made significant advancements with its Trillium™ technology, designed to provide functional tricuspid valve replacement through cross-caval anchoring and a unique multi-valve design. This technology aims to regulate blood flow effectively, thereby enhancing both the lifespan and quality of life for patients. Innoventric has successfully completed over ten implantations of the Trillium™ technology as part of its first clinical trial in Europe and maintains a robust patent portfolio covering its key innovations in tricuspid treatment.
INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.
Maynooth University is internationally recognised for quality and value of Their research and scholarship and Their dedication and commitment to teaching and Their students. Part of the NUI and formally established as an autonomous university in 1997, Maynooth University traces its origins to the foundation of the Royal College of St. Patrick in 1795, drawing inspiration from a heritage that includes over 200 years of education and scholarship. The University is a place of lively contrasts. It is a modern institution, dynamic, rapidly-growing, research-led and engaged, yet grounded in historic academic strengths and scholarly traditions.
Hideez is a cybersecurity startup that specializes in providing solutions for both physical and logical access. With offices in the USA and Ukraine, the company has developed the Hideez Key, a hybrid device designed for wireless authentication and password management. This innovative solution integrates RFID door credentials and digital signatures, utilizing encrypted Bluetooth, RFID, and NFC technologies. Hideez Key offers a versatile approach to authentication, enabling users to manage and replace credentials remotely. Its proprietary encryption protocols are platform agnostic and are designed to enhance existing solutions in the market. Overall, Hideez aims to simplify identity and access management while ensuring the security of digital assets.
Sequentia Biotech was founded in 2013 by Walter Sanseverino (CEO) and Riccardo Aiese Cigliano (CSO), two young researchers with a real passion for genetics and omics sciences, and is based at the UAB Research Park. Sequentia is a bioinformatics company that offers services and tools that transform genomic data into knowledge in academic research, plant and animal breeding and biomedicine. In just four years, Sequentia has achieved a large highly diversified portfolio of clients and partners, consisting of over 30 public and private research centers, companies and hospitals. The company is taking part in more than 160 R & D public and private projects, and it has two open source biodata banks; and an award-winning R&D line, Tricopharming, which was established in 2014. Cofounders Walter Sanseverino and Riccardo Aiese have published more than 40 scientific articles in high impact journals such as Nature Genetics, Scientific Report or DNA Research.
Ephos specializes in the development of integrated photonic circuits utilizing glass technology to improve computing capabilities. The company aims to minimize signal loss, facilitating innovative designs for both classical and quantum applications. By employing a proprietary manufacturing process, Ephos produces high-quality circuits tailored to the specific requirements of clients in the computational infrastructure sector. Their products are particularly suited for use in quantum computing, quantum communications, and quantum sensing, enabling customers to create scalable quantum infrastructures.
Reverion specializes in developing reversible, carbon-negative power plants that leverage patented technology to maximize the potential of biogas. The company's containerized units, designed for mass production, achieve remarkable electrical efficiencies of 80% for both power generation and energy storage. This innovative approach not only doubles the electricity output of traditional gas engines but also significantly reduces greenhouse gas emissions, resulting in a negative CO2 balance. Additionally, Reverion's technology is capable of utilizing excess solar and wind power, enhancing electricity production in existing biogas plants and stabilizing the power grid during electrolysis. Through these advancements, Reverion aims to promote a renewable and decarbonized energy future.
Treble Technologies develops advanced wave-based sound simulation products tailored for the architecture, engineering, and construction (AEC) industry. The company specializes in acoustics design software that enables the creation of visually accurate and realistic virtual acoustics. By streamlining the processes of importing, exporting, and reconfiguring models, Treble's solutions help reduce risk and ensure that designs meet regulatory and certification requirements. Their technology is applied across various sectors, including automotive, building design, immersive reality, and artificial intelligence. Through its innovative platform, Treble empowers studios and artists to lower costs, mitigate risks, and enhance client engagement while delivering high-quality designs.
Wattalps specializes in developing lithium power systems aimed at providing affordable battery solutions for small and medium series applications. The company's products prioritize passive safety, cooling efficiency, long life, and cell protection, facilitating the integration of these systems into vehicles and charging stations. With a focus on creating standard and modular designs, Wattalps aims to simplify installation processes, making them both fast and cost-effective. By advancing these technologies, the company contributes to the broader adoption of electric vehicles and sustainable transportation solutions.
Oryl Photonics develops a laboratory instrument for pharmaceutical and biotech companies that provides simple, reliable, cost-effective and sustainable solubility measurement to accelerate drug development for better and effective medicine.
Onego Bio is a food-based biotechnology company that produces animal-free egg white protein through precision fermentation. Their ingredient, Bioalbumen, sets a new standard for sustainable protein with identical taste and nutrition, superior functional properties, and over 90% smaller environmental footprint compared to eggs from chickens. Onego’s highly productive and scalable technology caters to the needs of the food industry searching for stable, sustainable functional ingredients. As a game-changer in the field, the company was selected as the Winner of Fast Company’s 2023 World Changing Ideas awards and is a co-founder of two industry associations: Precision Fermentation Alliance and Food Fermentation Europe.
dotLumen is a research startup that uses AI, robotics, and neuroscience to empower the blind. dotLumen was founded in 2020 and is headquartered in Cluj, Romania.
MediWound Ltd. is a biopharmaceutical company that specializes in the development, manufacturing, and commercialization of innovative therapeutic products aimed at addressing unmet medical needs, particularly in the areas of severe burns and chronic wounds. Founded in 2000 and headquartered in Yavne, Israel, it markets NexoBrid, a biopharmaceutical agent designed for the removal of eschar, or dead tissue, in patients with severe burns. NexoBrid has completed clinical development and is approved for use in Europe. The company is also advancing other products in its pipeline, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic wounds, and MWPC003 for connective tissue disorders. MediWound aims to improve patient outcomes and reduce the complications associated with traditional surgical interventions in wound management.
MediWound Ltd. is a biopharmaceutical company that specializes in the development, manufacturing, and commercialization of innovative therapeutic products aimed at addressing unmet medical needs, particularly in the areas of severe burns and chronic wounds. Founded in 2000 and headquartered in Yavne, Israel, it markets NexoBrid, a biopharmaceutical agent designed for the removal of eschar, or dead tissue, in patients with severe burns. NexoBrid has completed clinical development and is approved for use in Europe. The company is also advancing other products in its pipeline, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic wounds, and MWPC003 for connective tissue disorders. MediWound aims to improve patient outcomes and reduce the complications associated with traditional surgical interventions in wound management.
Endoron Medical specializes in the development of medical devices aimed at improving the treatment of abdominal aortic aneurysms. The company focuses on creating an endovascular suture device that enhances the effectiveness of endovascular aneurysm repair procedures. By designing long-lasting sealing equipment for endografts, Endoron Medical provides healthcare professionals with advanced technology to treat patients more effectively. This innovation is intended to improve patient outcomes and streamline surgical processes in the management of abdominal aortic aneurysms.
Axelera AI focuses on providing specialized hardware and software platforms to enhance artificial intelligence tasks, particularly in edge computing. Its primary product, the Metis™ AI Platform, combines hardware and software to offer high-performance, energy-efficient AI inference solutions. The platform's innovative design has earned recognition as a CES® 2024 Innovation Awards Honoree. Established in 2021 after incubation by Bitfury and collaboration with imec, Axelera AI is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices in Belgium, Switzerland, and Italy. The company's team comprises experts in AI from leading firms and Fortune 500 companies, focusing on delivering sustainable edge applications through a custom dataflow architecture and multicore in-memory computing that minimizes power consumption.
Innatera is an innovative developer of ultra-low power neuromorphic processors designed to enhance the efficiency of sensor data processing. Established in 2018 as a spin-off from the Delft University of Technology, the company focuses on creating processors that replicate the brain's mechanisms for sensory perception. Utilizing a novel continuous-time analog-mixed signal processing architecture, Innatera's chips can process sensor data up to 100 times faster while consuming up to 500 times less energy compared to traditional processors. This technology enables businesses to access and analyze sensor data more effectively, positioning Innatera as a leader in the field of energy-efficient computing solutions.
UroMems is a company dedicated to addressing specific clinical needs related to patient care, particularly in the area of urology. It develops implantable medical devices aimed at enhancing existing surgical treatments, thereby improving patient outcomes and reducing side effects. By focusing on innovative solutions, UroMems seeks to ensure that more patients can access effective treatments quickly, ultimately aiming to enhance their quality of life. The company is committed to the design, development, and commercialization of these active implantable devices, which reflect a deep understanding of the challenges faced by patients.
iOnctura is a biopharmaceutical company that develops novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which can hinder effective cancer treatment. The company focuses on creating next-generation biomolecules to enhance existing immune checkpoint therapies, ultimately aiming to improve patient outcomes in cancer treatment. Through collaborations with Merck and Cancer Research Technology, iOnctura is advancing a pipeline of preclinical molecules designed to be used in combination with immuno-oncology therapies. With access to state-of-the-art drug discovery laboratories and a network of academic partners, iOnctura is strategically positioned to develop innovative combination therapies in cancer immunology, ensuring a focused approach to tackling the complexities of cancer and fibrosis.
Qblox is a Dutch scaleup focused on quantum technology, specializing in the development of control hardware for quantum computers. The company offers patented, modular control systems that integrate hardware and software solutions designed to enhance the management of qubits. By creating a distributed processor architecture, Qblox simplifies experimental setups while improving gate fidelities through advanced electronics that reduce noise and drift. This innovation enables scientists to minimize crosstalk, implement low-latency control flows, and optimize measurement efficiency, addressing significant scientific and engineering challenges in the evolution of quantum computing. Qblox aims to support the transition from prototype quantum computers to powerful computational systems, thereby contributing to the broader advancement of quantum technology.
Bank of Memories helps to organize memories and documents and pass them on to the right people.
King's College London (informally King's or KCL) is a public research university located in London, United Kingdom, and a constituent college of the federal University of London. King's is arguably the third-oldest university in England, having been founded by King George IV and the Duke of Wellington in 1829, receiving its royal charter in the same year. St Thomas' Hospital, which is now a teaching hospital of King's College London School of Medicine, has roots dating back to 1173. In 1836, King's became one of the two founding colleges of the University of London. King's is based in the centre of London and organised into nine academic schools, spread across four Thames-side campuses in central London and another in Denmark Hill in south London. It is one of the largest centres for graduate and post-graduate medical teaching and biomedical research in Europe; it is home to six Medical Research Council centres for <a href="https://www.dissertationcorp.co.uk/">dissertation help</a> , the most of any British university, and is a founding member of the King's Health Partners academic health sciences centre. King's has around 25,000 students and 6,113 staff and had a total income of £587 million in 2012/13, of which £164 million was from research grants and contracts. King's is a world-leading university, currently ranked 19th in the world (6th in the UK and 8th in Europe) in the 2013 QS World University Rankings, and 38th in the world (6th in the UK and 9th in Europe) in the 2013 Times Higher Education World University Rankings. There are currently 12 Nobel Prize laureates amongst King's alumni and current and former faculty. King's is a member of the Association of Commonwealth Universities, the European University Association, the Russell Group and Universities UK. It forms part of the 'golden triangle' of British universities.
Tilkal is a Paris-based company founded in 2017 that specializes in supply chain traceability through its innovative software platform. This platform utilizes a B2B blockchain network to facilitate secure and verifiable data sharing among various supply chain stakeholders. Tilkal’s software captures traceability data from physical products in a ledger, enabling companies to obtain real-time insights into their supply chains. Customers leverage the platform to address critical questions regarding product location, sourcing risks, ESG commitments, and compliance verification. Notable clients include Danone, Daher, Joone, and the Responsible Mica Initiative, among others. The Tilkal network comprises over 70 independent nodes, with nearly 700 companies actively participating to share and analyze data, thereby enhancing the resilience, sustainability, and ethical standards of their supply chains.
ProFuse Technology specializes in advancing cultured meat production by enhancing methods and efficiency. The company has developed innovative technology that significantly reduces production time while improving meat quality and increasing yields. By accelerating muscle fiber growth, ProFuse enables meat producers to enhance their production capacity and lower costs, making cultured meat more accessible and sustainable.
Riverlane is a business focused on developing quantum computing software and engineering instruments to enhance the performance of quantum computers. The company collaborates with quantum computer manufacturers to create essential hardware and software tools that address the challenges posed by unstable qubits and system defects. By designing an ultra-low latency quantum operating system, Riverlane accelerates quantum-classical hybrid algorithms, thereby advancing hardware research and development. Their algorithms are specifically engineered to optimize the utilization of the complete quantum computing stack, helping hardware partners mitigate the system errors that currently hinder the effectiveness of quantum computers. Through these innovative solutions, Riverlane aims to transform experimental quantum technologies into viable commercial products.
Vitestro is a company focused on enhancing patient care through innovative autonomous blood drawing technology. It develops medical robotic devices tailored for use in hospitals and clinical laboratories. The company’s key product utilizes multi-dimensional ultrasound to detect nerves and arteries, leveraging deep learning to minimize the risk of arterial complications during blood draws. This advanced technology not only aids healthcare professionals in performing procedures with greater precision but also aims to improve overall patient health outcomes by reducing complications associated with traditional blood collection methods.
Vitestro is a company focused on enhancing patient care through innovative autonomous blood drawing technology. It develops medical robotic devices tailored for use in hospitals and clinical laboratories. The company’s key product utilizes multi-dimensional ultrasound to detect nerves and arteries, leveraging deep learning to minimize the risk of arterial complications during blood draws. This advanced technology not only aids healthcare professionals in performing procedures with greater precision but also aims to improve overall patient health outcomes by reducing complications associated with traditional blood collection methods.
3Deus Dynamics breakthrough innovation, a hybrid between 3D printing and injection/moulding, makes it possible to handle all the polymers available on the market without chemical reformulation, without support structure and without geometry limit.
Basemark Oy is a company based in Espoo, Finland, specializing in performance measurement tools and services for various industries, including mobile devices and automotive applications. Founded in 2015, it provides a range of benchmarking tools such as Basemark ES 3.1 for graphics performance comparisons, Basemark OS II for system-level performance measurement across platforms like Android and iOS, and Basemark X for evaluating gaming and graphics performance. Additionally, Basemark offers Browsermark for testing browser performance on multiple devices, as well as Basemark CL for measuring OpenCL implementations. The company also focuses on augmented reality (AR) software for the automotive sector, enabling original equipment manufacturers (OEMs) to develop advanced AR applications for vehicle functions, including navigation and heads-up displays. Basemark's tools support both benchmarking and AR development, catering to the needs of device manufacturers and semiconductor companies.
BOYDSense is a company based in South San Francisco, California, that specializes in developing non-invasive tools for measuring critical biomarkers through exhaled breath. Founded in 2015, the company focuses on breath-based metabolomics, which involves capturing, identifying, and quantifying volatile organic compound (VOC) biomarker patterns in human breath. This innovative approach aims to simplify the monitoring, screening, and risk stratification of chronic conditions, enabling medical professionals to diagnose and manage diseases more effectively.
e-peas SA is a Belgian company that specializes in designing and manufacturing electronic systems that enable energy autonomy for Internet of Things (IoT) applications. Founded in 2014 and based in Mont-Saint-Guibert, the company develops energy harvesting solutions that allow IoT devices to draw power from their environment, including sources such as solar, thermal, vibration, and radiofrequency. e-peas produces energy harvesting power management integrated circuits (PMICs) and low-power microcontrollers that enhance the performance and longevity of batteries in connected devices. By facilitating the efficient use of ambient energy, e-peas aims to reduce the need for frequent battery replacements across various sectors, including home automation, healthcare, and agriculture. The company's innovations contribute to making IoT devices smarter and more energy-efficient, ultimately striving for a future where devices can operate indefinitely without traditional power sources.
DRONAMICS is a cargo drone airline that develops drone technology for cargo transportation and logistics operations. The company is building an air cargo ecosystem to cater to the requirements of individuals and industries across the globe. This mobility solution, driven by long-range cargo drones, delivers savings in time, costs, and carbon emissions.
RS Research is a clinical-stage biotechnology company based in Istanbul, Turkey, focused on developing innovative nanomedicines for targeted cancer therapies. Founded in 2015, the company has established a proprietary drug delivery platform, Sagitta®, which enables the design of targeted drug candidates for various indications. RS Research's pipeline includes several proprietary programs in different stages of preclinical and clinical development, with its lead candidate, RS-0139, currently undergoing Phase I clinical trials in oncology patients. In addition to drug development, RS Research offers a range of services, including preclinical absorption, distribution, metabolism, and excretion studies, bioanalytical and analytical testing, and patent consulting. The company operates a GMP-certified production facility for clinical batch drug candidates and has successfully engaged in co-development projects with international partners, showcasing its commitment to advancing cancer treatment through modern therapeutic approaches.
Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Founded in 2019, the company specializes in creating quantum computing software that addresses complex financial and macro-economic challenges. Its products are tailored for various applications, including portfolio optimization, risk analysis, and market simulation. By leveraging probabilistic and nondeterministic technologies, Multiverse Computing aims to help organizations across diverse sectors such as banking, energy, manufacturing, and logistics navigate the complexities of the second quantum revolution, ultimately providing them with a competitive advantage in their respective industries.
Smart Farm Robotix manufactures agricultural robots that handle the difficulties of manual weeding, herbicide use, and machine weeding.
FreezeM is focused on advancing preservation technologies that enhance the use of insects as a sustainable protein source for the animal feed industry. The company is developing innovative methods for large-scale freezing of insects, which will facilitate the creation of global stocks of frozen insect neonates and eggs. This approach aims to address critical challenges related to the availability, cost, and regulatory hurdles associated with utilizing insects in animal feed. By ensuring a stable and year-round production of these beneficial insects, FreezeM seeks to make a significant impact on the animal feed market, while also contributing to biological pest control and species preservation.
Daze is an Italian hi-tech startup developing smart chargers for electric vehicles (EVs). Founded in 2016, Daze spent 3 years mainly focusing on pure R&D activities to create the first both autonomous and conductive charger for EVs: DazePlug. During 2020 Daze has also developed, started to produce and sell two “classic” EV charging products: DazeBox (for home charging) and DazeMax (for shared charging). In 2021 product sales exceeded 3,800 units and revenues approached 1.9 million Euro, with CAGR of 330% between 2019 and 2021. From June 2021 the company is also benefitting from a grant of 2.5 million Euro from the European Innovation Council (EIC) Fund, which is and will be used to push forward DazePlug development. In 2022 revenues grow over 5 million Euro with positive EBITDA, Daze Iberica started the operations. 2023 is the year of expansion, Daze France is starting the operations and new business models and new products are added to the business
Palobiofarma is a Spanish biotechnology company based in Barcelona's Science Park, dedicated to the discovery and development of new drugs that target adenosine receptors. The company aims to be a leader in adenosine drug discovery in Europe by focusing on innovative therapies. Palobiofarma specializes in creating selective adenosine receptor modulators, with a particular emphasis on addressing advanced prostate cancer. By leveraging medicinal chemistry and in vitro pharmacology, the company is working towards bringing its first marketed drug to the medical community, supporting healthcare professionals in their efforts to treat this challenging disease.
Heart Aerospace AB, founded in 2018 and headquartered in Gothenburg, Sweden, with an additional location in Palo Alto, California, focuses on developing an electric regional airliner aimed at enhancing sustainable transportation for regional travel. The company's flagship aircraft, the ES-19, is designed to accommodate nineteen passengers and boasts an operational range of 400 kilometers. Heart Aerospace seeks to significantly reduce fuel and maintenance costs compared to traditional aircraft while achieving zero operational emissions. The innovative design allows for a low infrastructural footprint, facilitating the use of small airports located near city centers. Heart's objective is to secure certification for the ES-19 for commercial operations by 2026, aligning with its mission to provide affordable and environmentally friendly travel options across the globe.
Infinite Roots is a technology-driven company focused on creating sustainable health and wellness products using natural ingredients. By blending traditional remedies with modern science, the company emphasizes the use of organic and ethically sourced materials to promote holistic well-being. Their product range includes herbal supplements, skincare, and wellness solutions designed to support natural healing and balance. Additionally, Infinite Roots has developed fermentation technology that cultivates mushroom mycelium, enabling the production of nutritious and sustainable food options, including meat alternatives. This innovative approach allows the company to offer diverse, flavorful products while maintaining a strong commitment to environmental sustainability and ethical practices.
Brite Solar is a nanomaterials company utilizing innovative materials and deposition techniques to deliver a new class of glass materials for building construction. Mankind's future may very well depend on how we manage food production, energy, water and land use. Solar energy production can be a key factor in this balancing act but the land demand is very high. Hydroponic greenhouse agriculture can be a great asset, but its energy requirements are high. The ideal answer is a self-sufficient and sustainable greenhouse technology which eliminates the need for external energy sources. Brite Solar is a nano-materials company that has developed a transparent solar glass technology based on Die Sensitized Solar Cells (DSSC) . The first target market is greenhouse solar glass, which enables the greenhouse to generate electricity needed for sustaining the internal environment. Using this solar glass, the greenhouse's carbon footprint is significantly reduced as its reliance on externally generated electricity is significantly reduced or eliminated. This is a great value proposition for the greenhouse operator since it reduces the operating cost for the greenhouse by 28% which is currently the cost attributed to energy. Brite's technology is based on nano-materials which are ink-jet printed on to glass panels, eliminating the expensive and complex production facilities needed to produce traditional solar panels. Variations of the technology will also be used to produce auto-dimming glass as well as architectural glass for building construction.
Aldoria specializes in space situational awareness, focusing on the collection, processing, and utilization of data to protect critical assets in space. The company addresses the growing challenges of space sustainability caused by increasing amounts of space debris and traffic. Its services encompass the detection, tracking, cataloging, and risk assessment of artificial satellites and space debris. By actively monitoring these elements, Aldoria helps operators and space organizations avoid potential hazards and adjust orbital paths, ultimately contributing to safer and more sustainable space operations. The company also provides users with a modern situational awareness platform and detailed sustainability reports.
QphoX develops a quantum modem device that facilitates the connection of quantum computers within a network. The company's technology includes a quantum transducer that utilizes a mechanical resonator to couple microwave and optical photons. This innovative approach enables the conversion of information between microwave and optical telecom frequencies, helping clients minimize loss and enhance the fidelity of quantum state transmission. By improving the connectivity of quantum systems, QphoX plays a crucial role in advancing quantum networking capabilities.
Wavess is an innovative predictive marketing analytics platform that utilizes advanced AI technologies to help businesses forecast the success of their marketing campaigns prior to launch. The platform combines AI algorithms with behavioral science to offer personalized recommendations, ultimately enhancing engagement and conversion rates. Targeting digital marketing agencies, scale-ups, and enterprises in sectors such as fintech, retail, and technology, Wavess provides critical insights into audience preferences and effective customer segmentation. Its distinctive features, including pre-launch prediction and ideal customer profiling, are designed to optimize campaign outcomes and facilitate tailored marketing strategies. In addition, the platform analyzes audience demographics and campaign seasonality to create customized posting schedules and identify valuable leads within a company's network, further improving overall campaign performance.
Sentante is a medical device company focused on developing robotic teleoperated systems specifically for endovascular procedures. By utilizing this innovative technology, Sentante enables physicians to perform surgeries remotely, significantly reducing their exposure to harmful X-rays. The company has designed a manipulator that assists endovascular practitioners in conducting procedures with minimal radiation risk, promoting safer practices in the medical field. Additionally, Sentante's robotic systems facilitate minimally invasive coronary procedures, enhancing the ability of surgeons to carry out complex endovascular surgeries while also contributing to a decrease in oncological diseases among healthcare personnel.
NETRIS Pharma S.A.S. is a biotechnology company based in Lyon, France, that specializes in identifying and developing therapeutic molecules aimed at treating cancer. The company's innovative approach focuses on targeting dependence receptors, which are trans-membrane proteins that play a crucial role in signaling within cells and regulating tumor development. NETRIS Pharma offers both in vitro and in vivo research services, along with preclinical practices, to advance drug manufacturing for various types of cancer, including breast cancer, lung cancer, glioblastoma, and neuroblastoma. Founded in 2008, the company is dedicated to contributing to the pharmaceutical industry by developing novel cancer therapies.
Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug and play solutions enable our customers to innovate their electronics without worrying about power supply units.
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing novel treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating antibacterial resistance-breakers that can restore the efficacy of existing antibiotics. Its key innovation includes inhibitors of bacterial metalloenzymes, specifically Metallo ß-lactamases (MBLs), which are designed to be used in combination with carbapenems to address significant treatment gaps in drug-resistant nosocomial infections. Antabio aims to provide health professionals with effective medicinal products to combat life-threatening respiratory infections, including carbapenem-resistant pneumonia and chronic pulmonary diseases. The company has received recognition for its research efforts, including a Wellcome Trust Seeding Drug Discovery Award.
Ignion is an antenna innovator based in Sant Cugat del Vallès, Spain, founded in 2015. The company specializes in manufacturing multiband, multipurpose antennas that cater to mobile and wireless connectivity requirements. Its product offerings include ready-to-use antennas designed for Internet of Things applications and short-range wireless devices, particularly suited for indoor environments. Ignion's solutions allow clients to seamlessly integrate these antennas into their industrial designs, facilitating efficient connectivity in various applications.
Quantum Diamonds specializes in the development of nitrogen-vacancy (NV) diamonds for quantum sensing applications. The company offers advanced quantum sensors that measure magnetic fields, temperature, and pressure, providing superior sensitivity and resolution compared to traditional sensors. These sensors are designed for use in various fields, including navigation, bio-imaging, geographical surveying, and spectroscopy, even under challenging conditions. By focusing on atom-sized quantum technologies, Quantum Diamonds enables industries and academic institutions to conduct precise analyses, optimizing for factors such as crystal lattice strain and charge state stability.
RespiQ is a healthtech startup that specializes in portable, non-invasive breath analysis technology aimed at the early detection and management of respiratory diseases. By utilizing advanced emission spectroscopy and artificial intelligence, RespiQ's device identifies volatile organic compounds (VOCs) in breath, enabling real-time detection of conditions such as COPD exacerbations. The company's focus on affordability, portability, and user-friendliness seeks to democratize access to advanced diagnostics, ultimately improving patient outcomes and reducing healthcare costs. In addition to respiratory diseases, RespiQ's versatile platform has potential applications for asthma, lung cancer, and infectious diseases. The company also offers an app that provides personalized health insights and dietary guidance, allowing users to monitor their health proactively. RespiQ's combination of technical and healthcare expertise positions it as a leader in breath diagnostics, with a commitment to enhancing overall health and well-being.
Efenco is a cleantech startup that is maximising the energy conversion efficiency of industrial furnaces and boilers and reducing their carbon footprints. Its flagship product, the patented high-energy ray ceramic chip (HERC), slashes CO2 and fuel costs by at least 18% in energy-intensive industries such as electricity generation, steel manufacturing, pulp and paper manufacturing, ceramics and cement production, and district heating.
Methinks is a developer of a medical imaging platform that leverages advanced artificial intelligence techniques, including Google's TensorFlow, to enhance the diagnosis of brain-related diseases, particularly acute stroke. The platform facilitates timely and universal diagnosis by using non-contrast CT imaging, which eliminates the need for contrast CT scans and significantly reduces time-to-treatment. This capability enables radiologists to effectively communicate with hospitals, stroke units, and other healthcare professionals, thereby improving the overall clinical response to stroke cases. By focusing on specific pathologies, Methinks aims to achieve clinical excellence in the diagnosis and management of neurological conditions.
NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
Acorai is developing a non-invasive heart failure monitoring platform centered on direct intracardiac pressure monitoring (ICPM). The company utilizes a patented combination of sensor technologies and machine learning to provide accurate and cost-efficient heart failure care. This innovative approach allows for non-invasive monitoring of cardiac and pulmonary pressure, which is crucial for improving outcomes in heart failure patients. By analyzing pressure dynamics through acoustic, vibratory, and waveform data, the device enables healthcare professionals to proactively adjust medications, potentially reducing re-hospitalization and mortality rates associated with heart failure. Clinically validated and designated as an FDA Breakthrough Device, Acorai's product is expected to enter the market in 2025.
Skytree is a company focused on developing innovative carbon dioxide solutions aimed at creating a cleaner and more sustainable environment. Founded in 2014, Skytree specializes in direct air capture (DAC) technology that efficiently extracts carbon dioxide from the atmosphere. This technology not only provides a reliable supply of usable CO2 for various industrial processes but also aids companies in transitioning away from fossil fuels. Skytree's advancements stem from over a decade of research originally aimed at addressing CO2 challenges for astronauts on the International Space Station. The company comprises a diverse team of scientists, engineers, and business professionals dedicated to promoting a circular carbon economy and contributing to a healthier planet.
Quandela is a company specializing in quantum computing, focusing on the development of communication networks and optical computers. It manufactures photonic quantum computers and markets them to industrial clients. The company's flagship product, a single-photon source device, integrates photonics with semiconductor quantum dots, facilitating quantum communication, computation, and sensing. This device allows for the efficient collection of emitted single photons at high rates, helping researchers minimize charge noise decoherence and achieve the emission of identical photons with high fidelity. These advancements are crucial for the progress of sophisticated quantum applications, positioning Quandela as a key player in the field of quantum technology.
RAIKU is a cleantech startup that produces 100% natural packaging material that has also great looks and shock absorption - most importantly, it gives 15-20 times more volume to its raw material making it one of the most resource efficient material uses in the world with high margins. Both the production is and products are clean making no harm to nature. RAIKU has raised over 1.2mln€ in the pre-seed stage, built a team of over 10 people, its own IP and clients are already using its packaging material. This material will up-end the 1 trillion € packaging sector.
ResoTher Pharma is a Copenhagen-based biotechnology company specializing in the development of peptide-based drugs aimed at treating cardiovascular and inflammatory disorders characterized by neutrophil-driven inflammation. The company focuses on leveraging the endogenous immunomodulator Annexin A1 to create therapeutic solutions that act as resolution therapy for diseases associated with innate immune activation. By targeting a specific G-protein coupled receptor on leukocytes, ResoTher Pharma's patented peptide drugs aim to mimic the body's natural mechanisms for resolving inflammation and promoting tissue healing, addressing significant unmet medical needs in the treatment of these conditions.
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for chipmakers focused on next-generation digital communications systems, particularly 5G networks. Established in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the necessity for DSP co-processors, thereby enhancing design flexibility. VSORA's innovative DSP development flow enables collaboration between signal processing engineers and software engineers, allowing them to work within the same environment and share source code, which significantly accelerates the time-to-market for new products. The company's mission is to address technical challenges by optimizing DSP computing power while minimizing power consumption and silicon footprint, thereby improving overall system performance.